Search

everythinglearnresearchcommunity

for

Search:↓

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Effective treatment significantly improves pododermatitis in dogs, reducing symptoms and extending remission.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Transplanted hair follicles show significant changes after FUE, needing more research.

Effective PCOS treatments require targeting specific signaling pathways.

The formulated gel is a promising treatment for alopecia areata.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Changes in skin bacteria can affect hair loss and new treatments targeting these bacteria may prevent balding without sexual side effects.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.